State Marijuana Regulators Tell Congress To Focus On More Than Just CBD By Regulating Other Cannabinoids Like Delta-8 THC

State Marijuana Regulators Tell Congress To Focus On More Than Just CBD By Regulating Other Cannabinoids Like Delta-8 THC

As the popularity of cannabis products continues to grow in the US, state marijuana regulators are advocating for increased regulation of other cannabinoids – such as Delta-8 THC – in addition to CBD. These regulators believe that Congress needs to consider more than just CBD when regulating cannabis in the country. With this push, states are hoping to create better controlled substances policies that can prevent abuse and misusage, all while ensuring that those with legitimate medical needs have access to the right products.

1. Congress’ Focus on CBD Widens with Regulations on Other Cannabinoids

It appears that the US Congress’ dissection of cannabis as a regulated health and wellness product has continued to broaden. As of late, certain cannabinoids, especially cannabidiol (CBD), have been the central and most studied element of the cannabis plant. Although CBD has been highly praised for its potential therapeutic and healing properties, it has become obvious that other cannabinoids in the plant could be of great importance and value.

Now US Congress is proposing regulations that would not only legalize certain hemp-based products that test positive for CBD, but also other elements of the plant, such as cannabinol (CBN), cannabigerol (CBG), and cannabichromene (CBC). These measures have been proposed in several Senate bills and in some state legislation, with hopes of making these products widely available to consumers in a safe, effective, and responsible way.

The Regulations Include:

  • Legalization of products that test positive for CBD and other cannabis-related compounds
  • Adoption of new safety protocols for cannabis-based health and wellness products
  • Mandating of quality testing on cannabis-based products
  • Officially recognizing the therapeutic potential of cannabis-based products

These new regulations demonstrate a much greater investment into the research and utilization of cannabinoids, setting the stage for a potential paradigm shift in the way cannabis is viewed and employed. It remains to be seen what the full implications of these measures are; however, one thing is certain, with Congress’ new focus, cannabinoids are becoming an increasingly valuable part of the medicinal landscape.

2. The Need for Regulation of Delta-8 THC and Other Cannabinoids

The continued rise in popularity of cannabinoids such as Delta-8 THC has made it necessary to start discussing the legal implications of these compounds. With the majority of states in the US and other countries beginning to legalize substances containing trace amounts of THC, the need for a proper system of regulation has become increasingly important.

The need to establish restrictions and clarity in regards to the sale, consumption, and possession of cannabinoids is paramount. Without the proper regulation, individuals could find themselves inadvertently breaking the law or consuming products that contain unknown quantities of the compound. To further complicate matters, the chemical properties of Delta-8 THC make it a particularly dangerous substance for abuse. This regulation would ensure that morally and legally acceptable levels of cannabinoids are available for those who need and use them.

  • Outline clear requirements for legal cannabinoids
  • Delineate acceptable consumption levels
  • Offer guidance and information regarding potential risks

3. State Marijuana Regulators Urge Congress to Expand Focus Beyond CBD

State marijuana regulators are branching out in their focus to include more than just CBD in their list of federally legal cannabis products. In response to a survey released by the National Association of Cannabis Business (NACB), a majority of state regulatory authorities are now urging Congress to move beyond CBD, and into the realm of THC-containing marijuana products as well.

The survey asked the 54 state and local cannabis regulators at the helm of the booming marijuana industry a variety of questions, the answers of which paint a picture of an industry ready for broader legalization. Over 80 percent of those questioned agreed that the current rules for cannabis in the United States create inconsistencies and barriers that limit the industry’s ability to innovate and grow.

Additionally, the survey includes some other key data points that support the move towards more comprehensive cannabis legislation. Respondents indicated that passage of the STATES Act, which would give states greater autonomy in governing cannabis-related activities, was strongly supported. Furthermore, most regulators felt that marijuana businesses should have access to the same banking and capital services available to other businesses, as well as the opportunity to list on public stock exchanges.

It’s clear that state marijuana regulators are urging Congress to expand their focus beyond CBD – and into the realm of THC-containing marijuana products – in order to address the inconsistencies and barriers currently preventing the industry from expanding. With the survey results indicating that so many state regulators back these measures, it will be interesting to see what, if any, action Congress takes in the near future.

4. Cannabinoid Laws: It’s Time for Congress to Take Action

The U.S. Has Fallen Behind Other Countries

The United States has fallen behind other countries in terms of cannabinoid laws. In Canada, the government has allowed marijuana to be legal for both medical and recreational use. Other countries such as Israel, and some countries in Europe have also begun to legalize cannabis in various forms.

The U.S., however, has not taken the same steps to legalize and regulate cannabinoids. With no real federal rules in place, states are left to create their own laws without truly knowing the impact of those regulations. This has been especially true for states that have had to grapple with the issue of medical marijuana legalization.

It’s Past Time for Congress to Act

It’s time for the United States Congress to step in and take action. A federal law is necessary to guide the states in how they approach these issues, as the current patchwork of regulations and laws is confusing and sometimes contradictory. Congress needs to create clear and definitive rules so that states and individuals can follow them and remain within the law.

This will also ensure consistency across the country, and create opportunities for businesses, researchers, and the public to make informed decisions about cannabinoids. If nothing else, Congress must at least create a cooperative framework for state legislatures to operate within, giving them more clarity about how to proceed.

With this bipartisan legislative proposal, state regulators are looking to put forth reasonable regulations on marijuana — and its various components — to offer more comprehensive cannabis safety and consumption. While this effort may not result in an immediate shift due to various legal hurdles, it has the potential to lay the groundwork for a much different cannabis marketplace. The experience of state regulators as well as the insight of knowledgeable industry experts will be instrumental in aiding Congress in their efforts — and that is something worth keeping an eye on!

Comments

Leave a Reply

Your email address will not be published. Required fields are marked *